Resveratrol (RSV) could promote osteogenic activity,but its clinical application has been hampered in view of its poor bioavailability.Therefore,it is desirable to identify with certainty the molecular target of its bone mass boosting function,which is crucial to the design of an effective therapeutic strategy for the optimal treatment of osteoporosis.Emerging evidence has indicated that GATA-1,an important transcription factor in megakaryocyte and erythrocyte differentiation,can directly activate autophagy in erythrocytes,alluding to its impact on bone metabolism.In light of this,we sought to determine whether GATA-1 would be a putative target by which RSV would act on osteoblast proliferation and,if so,to explore the underlying mechanism involved in the process.We examined the cell viability,colony formation,cell cyclin expression,autophagy level,and the expression levels of GATA-1 and adenosine 5\'-monophosphate (AMP)-activated protein kinase α(AMPKα) in osteoblastic cell strain MC3T3-E1.The results showed that RSV promoted the prolif-eration process in MC3T3-E1 coupled with increased expression of GATA-1 and phosphorylated AMPKα and activated autophagy.When GATA-1 was interfered with siRNA,both autophagy and proliferation were decreased.Administration of the agonist of phosphorylated AMPKoα1 (Thr172)promoted the translocation of GATA-1 into the nucleus.Based on the above results,we concluded that RSV induces the proliferation of MC3T3-E1 by increasing GATA-1 expression,which thence activates autophagy;and of note,AMPKα is one of the upstream regulators of GATA-1.